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ABSTRAK 
Ujian diagnostik segera malaria (RDT) bertindak sebagai imunoassay berasaskan 
antibodi penting untuk diagnosis segera malaria. Antibodi monoklonal konvensional 
(mAbs) digunakan secara meluas dalam RDT tetapi ia mudah merosot pada suhu 
persekitaran tinggi. Oleh itu, VNARS dari ikan yu mungkin merupakan alternatif yang 
baik untuk mAbs kerana kestabilan haba dan kekuatan gabungan dengan antigen 
yang lebih tinggi. Dalam kajian ini, anti-PfHRP2 VNAR-G1 protein rekombinan akan 
dihasilkan dalam sistem ekspresi E. coli BL21(DE3) melalui pelbagai langkah seperti 
pengasingan sel rekombinan, PCR, elektroforesis gel agarosa, pengekstrakan 
plasmid, transformasi dan ekspresi protein. Selain itu, kesan gabungan suhu dan 
kepekatan IPTG terhadap kepadatan sel rekombinan BL21(DE3) berdasarkan bacaan 
serapan dan berat basah sel dianalisis menggunakan perisian R. Berdasarkan analisis 
statistik ANOVA 2-arah dan regresi berbilang pemboleh ubah, kedua-dua faktor 
ekspresi mempunyai interaksi gabungan yang sangat signifikan (p < 0.05) terhadap 
bacaan serapan dan berat basah sel. Analisis korelasi antara kepekatan IPTG dan 
bacaan serapan adalah signifikan (p < 0.05) dengan pekali korelasi Pearson yang 
tinggi (0.9512). Kemunculan anti-PfHRP2 VNAR-G1 protein rekombinan dengan 
ukuran molekul sekitar 12 kDa dikesan dan disahkan melalui analisis SDS-PAGE 
dan western blot. Kepekatan protein ditentukan sebagai 0.209 mg/mL dari 0.406 g 
ekstrak sel kasar. Kesimpulannya, semua objektif dalam kajian ini tercapai dan sdAb 
rekombinan dari VNAR ikan yu khusus untuk gabungan PfHRP2 berjaya dihasilkan 
dalam E. coli BL21(DE3) sebagai sumber ekspresi. 
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PRODUCTION OF NOVEL RECOMBINANT ANTI-PFHRP2 VNAR-G1 
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ABSTRACT 
Malaria rapid diagnostic tests (RDTs) act as important antibody-based immunoassays 
for prompt malaria diagnosis. Conventional monoclonal antibodies (mAbs) are 
widely used in RDTs but it can be easily degraded at high ambient temperatures. 
Hence, the shark VNARS might be good alternatives to mAbs due to its higher thermal 
stability and binding affinity with antigens. In this study, the recombinant anti-
PfHRP2 VNAR-G1 protein was produced in E. coli expression system through various 
steps such as recombinant cell isolation, PCR, agarose gel electrophoresis, plasmid 
extraction, transformation and protein expression. Besides, the combinatorial effects 
of temperature and IPTG concentration towards the cell density of recombinant 
BL21(DE3) based on the absorbance readings and cell wet weights were investigated 
using software R. Based on the statistical analysis of 2-way ANOVA and multi-
variable regression, both expression variables had highly significant combined 
interactions (p < 0.05) towards absorbance readings and cell wet weights. There was 
significant and strong positive correlation between IPTG concentrations and 
absorbance readings (p < 0.05, r = 0.9512). The presence of recombinant anti-
PfHRP2 VNAR-G1 protein with a molecular size of about 12 kDa was detected and 
confirmed through SDS-PAGE and western blot analysis. The protein concentration 
was determined as 0.209 mg/mL from 0.406 g of crude cell extract. In conclusion, all 
the objectives in this study were achieved and the recombinant sdAb from shark 
VNAR specific for PfHRP2 binding was successfully produced in E. coli BL21(DE3) 
as the expression host. 
